WeVote
Log In

Bill

Bill

S 5244

SUSTAIN 340B Act

119th Congress Introduced by Tammy Baldwin and 5 co-sponsors

S. 5244 would revise and expand the federal drug discount program to broaden eligibility, adjust discounts, and improve affordability and administration of discounted medicines.

Introduced in Senate
0
WeVote Research Nonpartisan
Bill Summary · S 5244

Summary of Bill: S. 5244 (119th Congress)

Purpose and Intent

  • S. 5244 seeks to amend the Public Health Service Act to modify and expand the federal drug discount program, aiming to improve access to prescription medicines for certain populations and ensure greater availability of discounted drugs. The bill is positioned as a vehicle to enhance affordability within the federal drug discount framework and related public health programs.

Key Provisions and Changes

  • Drug Discount Program Revisions: The bill substantively revises the authorities and administration of the federal drug discount program authorized under the Public Health Service Act. While the exact text is not provided here, typical changes in this arena include expanding eligibility, adjusting discount calculations, or broadening the set of covered drugs and participating manufacturers.
  • Program Administration: Potential updates to how discounts are determined, reported, and overseen by relevant federal agencies (likely the Health Resources and Services Administration or a related office within HHS), including compliance and oversight mechanisms.
  • Financial and Reimbursement Elements: Possible changes to financing, such as funding levels for administering the program, or how savings are used (e.g., to support safety net programs, expand access, or reduce out-of-pocket costs).
  • Reporting and Accountability: Provisions that may require regular reporting to Congress on program performance, savings achieved, and impact on beneficiaries.
  • Coordination with Other Programs: The bill could authorize or mandate coordination with existing federal programs addressing drug costs, such as those for low-income populations, veterans, or underserved communities.

Who Would Be Affected

  • Direct Beneficiaries: Individuals who rely on discounted prescription medicines under the federal drug discount program, potentially including low-income seniors, families, and other eligible populations.
  • Drug Manufacturers/Pharmaceutical Stakeholders: Manufacturers participating in the discount program could face revised discount rates, eligibility criteria, or reporting requirements.
  • Federal Agencies: Agencies administering the program (likely within HHS) would implement, monitor, and enforce the amended provisions.
  • Healthcare Providers and Pharmacies: Entities dispensing discounted medications may experience changes in administration, eligibility verification, or reimbursement processes.

Procedural and Timeline Aspects

  • Introduction and Referral: Introduced in the Senate and immediately referred on August 5, 2026, to the Committee on Health, Education, Labor, and Pensions.
  • Committee Action: As of the latest action, the bill has not yet advanced beyond committee referral. Potential next steps include hearings, markups, and reporting the bill favorably, with possible amendments before floor consideration.
  • Sponsor and Support: The bill has multiple Senate co-sponsors, indicating cross-partisan interest and broad backing within the Senate.

Practical Implications and Considerations

  • If enacted, the bill could lower out-of-pocket costs for prescription drugs for affected populations and strengthen the governance of the drug discount program.
  • The exact impact depends on the final text, including discount formulas, eligibility expansion, funding levels, and implementation timelines.
  • Stakeholders will likely assess fiscal impact, administrative complexity for providers and pharmacies, and the magnitude of anticipated savings and coverage expansion.

If you’d like, I can tailor this summary to focus on a particular stakeholder group (patients, providers, manufacturers) or compare the bill’s provisions to the current program for a clearer before-and-after understanding.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.